Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used PARP inhibitors. A new study from Mayo Clinic researchers reports that ovarian cancer cells can quickly switch on a survival response after treatment with PARP inhibitors. Blocking this early reaction may help these drugs work more [...] 
Bengali (Bangladesh) · 
English (United States) ·